Clorox Q2 FY2026 sales down 1% to $1.67B, EPS $1.29, reaffirms outlook

CLOROX CO /DE/

2026-Q2 EPS reported $1.93 revenue$3,102,000,000

Net sales $1.67B (-1% YoY); organic sales -1%; gross margin 43.2% (-60 bps).
Diluted EPS $1.29 (-16% YoY); adjusted EPS $1.39 (-10% YoY).
YTD operating cash flow $404M (+1%); free cash flow $326M (10.5% of sales).
Segment: Health & Wellness +2%, Household -6%, Lifestyle -5%, International +7%.
CEO Linda Rendle reaffirms FY2026 outlook; cites recently announced GOJO acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.